Entrada Therapeutics Inc

NASDAQ:TRDA   3:59:54 PM EDT
8.00
-0.64 (-7.41%)
Earnings Announcements

Entrada Therapeutics Reports Third Quarter 2021 Financial Results

Published: 12/09/2021 12:51 GMT
Entrada Therapeutics Inc (TRDA) - Entrada Therapeutics Reports Third Quarter 2021 Financial Results.
Entrada Therapeutics Inc - Qtrly Net Loss per Share Attributable to Common Stockholders $9.78.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.80

More details on our Analysts Page.